15 Jan CREATE Medicines
Posted at 20:34h
in
Daniel Getts, Ph.D., CEO
April 29 | 9:45am | Salone dei Cavalieri, Section 1
Cambridge, MA,
(Private)
CREATE Medicines is a clinical-stage biotech pioneering in vivo multi-immune programming. Its proprietary mRNA-LNP platform directly programs immune cells inside the body to deliver scalable, repeat-dose, off-the-shelf immunotherapies. With proven human validation and next-generation RNA technology, CREATE is advancing a pipeline of in vivo CAR therapies to transform outcomes in cancer and autoimmunity.
